Terms: = Endocrine gland cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Clinical Outcome
17 results:
1. Genetic and epigenetic characterization of posterior pituitary tumors.
Schmid S; Solomon DA; Perez E; Thieme A; Kleinschmidt-DeMasters BK; Giannini C; Reinhardt A; Asa SL; Mete O; Stichel D; Siewert C; Dittmayer C; Hasselblatt M; Paulus W; Nagel C; Harter PN; Schittenhelm J; Honegger J; Rushing E; Coras R; Pfister SM; Buslei R; Koch A; Perry A; Jones DTW; von Deimling A; Capper D; Lopes MB
Acta Neuropathol; 2021 Dec; 142(6):1025-1043. PubMed ID: 34661724
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Profiling of Thyroid cancer Reveals a Role for Thyroglobulin in Metastasis.
Siraj AK; Masoodi T; Bu R; Beg S; Al-Sobhi SS; Al-Dayel F; Al-Dawish M; Alkuraya FS; Al-Kuraya KS
Am J Hum Genet; 2016 Jun; 98(6):1170-1180. PubMed ID: 27236916
[TBL] [Abstract] [Full Text] [Related]
3. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract] [Full Text] [Related]
4. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
[TBL] [Abstract] [Full Text] [Related]
5. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy.
Schechter RB; Nagilla M; Joseph L; Reddy P; Khattri A; Watson S; Locati LD; Licitra L; Greco A; Pelosi G; Carcangiu ML; Lingen MW; Seiwert TY; Cohen EE
Cancer Lett; 2015 Apr; 359(2):269-74. PubMed ID: 25641339
[TBL] [Abstract] [Full Text] [Related]
6. Combining clinicopathological predictors and molecular biomarkers in the oncogenic k-ras/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.
Qin R; Smyrk TC; Reed NR; Schmidt RL; Schnelldorfer T; Chari ST; Petersen GM; Tang AH
Br J Cancer; 2015 Feb; 112(3):514-22. PubMed ID: 25584484
[TBL] [Abstract] [Full Text] [Related]
7. Pancreatic cancer-improved care achievable.
Buanes TA
World J Gastroenterol; 2014 Aug; 20(30):10405-18. PubMed ID: 25132756
[TBL] [Abstract] [Full Text] [Related]
8. Novel synthetic oleanane triterpenoid AMR-MeOAc inhibits k-ras through ERK, Akt and survivin in pancreatic cancer cells.
Rabi T; Venkatanarashiman M
Phytomedicine; 2014 Mar; 21(4):491-6. PubMed ID: 24215674
[TBL] [Abstract] [Full Text] [Related]
9. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract] [Full Text] [Related]
10. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.
Chang DZ; Ma Y; Ji B; Wang H; Deng D; Liu Y; Abbruzzese JL; Liu YJ; Logsdon CD; Hwu P
Clin Cancer Res; 2011 Nov; 17(22):7015-23. PubMed ID: 21976550
[TBL] [Abstract] [Full Text] [Related]
11. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract] [Full Text] [Related]
12. High-dose chemotherapy for male germ cell tumor.
Hara I; Miyake H; Yamada Y; Takenaka A; Fujisawa M
Int J Urol; 2006 Aug; 13(8):1037-44. PubMed ID: 16903926
[TBL] [Abstract] [Full Text] [Related]
13. Osteoclast-like giant cell tumor in mucinous cystadenocarcinoma of the pancreas: an immunohistochemical and molecular analysis.
Sedivy R; Kalipciyan M; Mazal PR; Wolf B; Wrba F; Karner-Hanusch J; Mühlbacher F; Mader RM
Cancer Detect Prev; 2005; 29(1):8-14. PubMed ID: 15734212
[TBL] [Abstract] [Full Text] [Related]
14. k-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
[TBL] [Abstract] [Full Text] [Related]
15. Detection and clinical correlations of ras gene mutations in human ovarian tumors.
Varras MN; Sourvinos G; Diakomanolis E; Koumantakis E; Flouris GA; Lekka-Katsouli J; Michalas S; Spandidos DA
Oncology; 1999; 56(2):89-96. PubMed ID: 9949292
[TBL] [Abstract] [Full Text] [Related]
16. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
[TBL] [Abstract] [Full Text] [Related]
17. A prospective study of k-ras mutations in the plasma of pancreatic cancer patients.
Mulcahy HE; Lyautey J; Lederrey C; qi Chen X; Anker P; Alstead EM; Ballinger A; Farthing MJ; Stroun M
Clin Cancer Res; 1998 Feb; 4(2):271-5. PubMed ID: 9516910
[TBL] [Abstract] [Full Text] [Related]
